Molecular pathway may help reduce damage after heart attack

December 14, 2011 in Cardiology

(Medical Xpress) -- UH Manoa’s John A. Burns School of Medicine (JABSOM) Assistant Professor Michelle Matter and her colleagues in the Department of Cell and Molecular Biology and the Center for Cardiovascular Research have discovered a molecular pathway that may help reduce the damaging effects of an enlarged heart, caused by hypertension or a heart attack.

Enlargement of the , called cardiac hypertrophy, stretches cardiac cells, causing the cells to release Vascular Endothelial Growth Factor (VEGF). VEGF helps protect cardiac function and keep cardiac cells alive.

“We have found that stretch of adult promotes release of VEGF through activation of the NFkB signaling pathway,” said Dr. Matter, an Assistant Professor of Molecular Biology. “Targeting this molecular pathway may alleviate the pathological effects of hypertrophy and increase survival of patients who have had a or suffer hypertension.”

Matter’s research, conducted in conjunction with Dr. Eugene Konorev at the University of Hawai’i at Hilo, is published today in PLoS ONE, a peer-reviewed medical journal. The research was funded by the National Center for Research Resources, part of the National Institutes of Health.

More than 3,100 people in Hawai’i die of cardiovascular disease every year, according to The Burden of Heart Disease in Hawai’i, a report to the Hawai’i State Department of Health (DOH).

Further, the report suggests as many as 70% of the adults in Hawai’i have at least one risk factor for cardiovascular disease, including diabetes, hypertension and obesity.

Residents of Hawai’i Island, Native Hawaiians, Filipinos, and the poor have higher risks for , according the DOH report.

Ways to lessen your risk for heart disease include lowering high blood pressure, reducing high cholesterol, not smoking, engaging in more physical activity, managing diabetes, and controlling weight.

More information: Dr. Matter's paper is published on line at: http://www.plosone … pone.0029055

Provided by University of Hawai'i at Manoa

not rated yet  

Rank not rated yet
Relevant PhysicsForums posts
  • Force in a magnetic coupling
    created9 hours ago
  • Sign of scalar product in electric potential integral?
    created16 hours ago
  • Heat engines: how can we yield work?
    created17 hours ago
  • Work done by us on the spring
    createdMay 25, 2012
  • Surface current density
    createdMay 25, 2012
  • Work done on body moving in a circle
    createdMay 25, 2012
  • More from Physics Forums - Classical Physics

More news stories

One-fifth of healthy middle-aged men have low-grade murmur

(HealthDay) -- More than one-fifth of healthy middle-aged men have a low-grade systolic heart murmur that confers a nearly five-fold higher risk of future aortic valve replacement (AVR), according to a study ...

Cardiology created May 25, 2012 | popularity not rated yet | comments 0

New device allows pacemaker patients to safely undergo MRIs

For many, it's a medical conundrum: The very pacemaker keeping their heart in rhythm prevents them from undergoing an MRI to diagnose other ailments, because interaction between the two devices could prove deadly.

Cardiology created May 25, 2012 | popularity not rated yet | comments 0 | with audio podcast

New study should end debate over magnesium treatment for preventing poor outcome after haemorrhagic stroke

An international randomised trial and meta-analysis published Online First in The Lancet should put an end to the debate about the use of intravenous magnesium sulphate to prevent poor outcomes after haemorrhagic stroke. The in ...

Cardiology created May 25, 2012 | popularity not rated yet | comments 0

Low vitamin D in diet increases stroke risk in Japanese-Americans

Japanese-American men who did not eat foods rich in vitamin D had a higher risk of stroke later in life, according to results of a 34-year study reported in Stroke, an American Heart Association journal.

Cardiology created May 24, 2012 | popularity not rated yet | comments 0

Clot buster seems to help up to 6 hours after stroke

(HealthDay) -- The largest study of its kind finds that stroke patients benefit from a clot-busting drug even six hours after a stroke, suggesting that the current recommended 4.5-hour limit could be expanded.

Cardiology created May 24, 2012 | popularity not rated yet | comments 0


Travel to high altitudes tied to Crohn's, colitis flare-ups

(HealthDay) -- People with inflammatory bowel disease, which includes Crohn's disease and colitis, may be at increased risk for flare-ups when they fly or travel to high altitudes for skiing or mountain climbing, ...

Family history of Alzheimer's affects functional connectivity

(HealthDay) -- Cognitively normal individuals with a family history of late-onset Alzheimer's disease (AD) may display lower resting state functional connectivity in the default mode network (DMN) of the brain, ...

Transvaginal mesh op restores pelvic organ prolapse at price

(HealthDay) -- Transvaginal mesh (TVM) procedures are effective for anatomical restoration of pelvic organ prolapse (POP), but patients report a worsening of sexual function following surgery, according to ...

Of mice and mental models: Neuroscientific implications of risk-optimized behavior in the mouse

(Medical Xpress) -- Regardless of an organism’s biological complexity, every encephalized animal continuously makes under-informed behavioral choices that can have serious consequences. Despite its ubiquity, ...

Weight struggles? Blame new neurons in your hypothalamus

New nerve cells formed in a select part of the brain could hold considerable sway over how much you eat and consequently weigh, new animal research by Johns Hopkins scientists suggests in a study published in the May issue ...

Thioridazine kills cancer stem cells in human while avoiding toxic side-effects of conventional cancer treatments

A team of scientists at McMaster University has discovered a drug, thioridazine, successfully kills cancer stem cells in the human while avoiding the toxic side-effects of conventional cancer treatments.